PTEN deletions and/or mutations are found in 30% of primary prostate cancers [29] and 63% of metastatic prostate tissue samples [30], placing PTEN mutation among the most common genetic alterations reported in human prostate cancers. The gene discussed is PTEN; the disease is prostate carcinoma.